UK markets open in 5 hours 26 minutes

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
26.96-0.87 (-3.13%)
At close: 04:00PM EDT
26.10 -0.86 (-3.19%)
After hours: 07:54PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
4,140
4,651
7,418
3,573
9,538
Operating expenses
Research development
57,647
53,311
42,534
42,672
66,449
Selling general and administrative
23,278
20,488
14,456
15,426
19,269
Total operating expenses
80,925
73,799
56,990
58,098
85,942
Operating income or loss
-76,785
-69,148
-49,572
-54,525
-76,404
Total other income/expenses net
-465
-1,590
-11,375
3,647
-75,545
Income before tax
-77,250
-70,738
-60,947
-50,878
-151,949
Income tax expense
-
-227
-1,167
0
-765
Income from continuing operations
-77,023
-70,511
-59,780
-50,878
-151,184
Net income
-77,023
-70,511
-59,780
-50,878
-151,184
Net income available to common shareholders
-77,023
-70,511
-59,780
-50,878
-151,184
Basic EPS
-
-1.64
-2.02
-3.51
-14.48
Diluted EPS
-
-1.64
-2.02
-3.51
-14.48
Basic average shares
-
42,870
29,640
14,507
10,442
Diluted average shares
-
42,870
29,640
14,507
10,442
EBITDA
-
-66,080
-45,643
-49,667
-72,603